Cargando…
Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC)
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288787/ http://dx.doi.org/10.1186/2051-1426-2-S3-P98 |
| _version_ | 1782352023185784832 |
|---|---|
| author | Duffy, Austin Kerkar, Sid P Kleiner, David E Ulahannan, Susanna Kurtoglu, Metin Rusher, Oxana Fioravanti, Suzanne Walker, Melissa Figg, William D Compton, Kathryn Venkatesan, Aradhana Abi-Jaoudeh, Nadine Wood, Brad Greten, Tim F |
| author_facet | Duffy, Austin Kerkar, Sid P Kleiner, David E Ulahannan, Susanna Kurtoglu, Metin Rusher, Oxana Fioravanti, Suzanne Walker, Melissa Figg, William D Compton, Kathryn Venkatesan, Aradhana Abi-Jaoudeh, Nadine Wood, Brad Greten, Tim F |
| author_sort | Duffy, Austin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288787 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42887872015-01-15 Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC) Duffy, Austin Kerkar, Sid P Kleiner, David E Ulahannan, Susanna Kurtoglu, Metin Rusher, Oxana Fioravanti, Suzanne Walker, Melissa Figg, William D Compton, Kathryn Venkatesan, Aradhana Abi-Jaoudeh, Nadine Wood, Brad Greten, Tim F J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288787/ http://dx.doi.org/10.1186/2051-1426-2-S3-P98 Text en Copyright © 2014 Duffy et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Duffy, Austin Kerkar, Sid P Kleiner, David E Ulahannan, Susanna Kurtoglu, Metin Rusher, Oxana Fioravanti, Suzanne Walker, Melissa Figg, William D Compton, Kathryn Venkatesan, Aradhana Abi-Jaoudeh, Nadine Wood, Brad Greten, Tim F Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC) |
| title | Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC) |
| title_full | Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC) |
| title_fullStr | Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC) |
| title_full_unstemmed | Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC) |
| title_short | Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC) |
| title_sort | paired tumor biopsy analysis and safety data from a pilot study evaluating tremelimumab - a monoclonal antibody against ctla-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (hcc) |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288787/ http://dx.doi.org/10.1186/2051-1426-2-S3-P98 |
| work_keys_str_mv | AT duffyaustin pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT kerkarsidp pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT kleinerdavide pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT ulahannansusanna pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT kurtoglumetin pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT rusheroxana pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT fioravantisuzanne pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT walkermelissa pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT figgwilliamd pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT comptonkathryn pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT venkatesanaradhana pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT abijaoudehnadine pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT woodbrad pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc AT gretentimf pairedtumorbiopsyanalysisandsafetydatafromapilotstudyevaluatingtremelimumabamonoclonalantibodyagainstctla4incombinationwithablativetherapyinpatientswithhepatocellularcarcinomahcc |